company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19024000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19024000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4898000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4518000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11869000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6389000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8818000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8818000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,340000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,639000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,979000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,979000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,568000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3003000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2010.0,FY,2009-04-01,2010-03-31,2012-06-04 15:34:33+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,940000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1835000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-857000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,146000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,146000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-251000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-251000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,805000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,805000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1638000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3948000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1467000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1804000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8004000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,456000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2352000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2352000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1061000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,447000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,FY,2010-04-01,2011-03-31,2013-05-28 16:33:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1043000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,904000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2293000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3468000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-463000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5464000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5464000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-430000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3008000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6079000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1428000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1428000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1054000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,456000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2101000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2101000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,416000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-491000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3YTD,2010-04-01,2010-12-31,2012-02-08 16:05:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-595000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1145000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1705000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-302000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,249000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,682000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2104000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3786000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4435000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4435000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-591000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1502000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,456000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,343000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,496000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,496000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-61000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2YTD,2010-04-01,2010-09-30,2011-11-07 16:58:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-637000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,959000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1813000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,561000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2647000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2647000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-289000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,239000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,94000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,94000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,94000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-743000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1253000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2679000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1506000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,192000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,123000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-234000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,898000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1495000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1495000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4336000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8759000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10956000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3634000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3634000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1745000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24502000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17480000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17480000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,423000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14257000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-675000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,159000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,FY,2011-04-01,2012-03-31,2014-05-28 15:17:02+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7915000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10307000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1213000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1213000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2687000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10017000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11173000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11173000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,460000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12328000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,497000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3TTM,2011-01-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,958000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-427000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1017000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,103000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3986000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3986000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-379000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1072000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1072000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3083000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6080000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9450000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1937000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17002000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8017000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11683000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11983000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-441000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3YTD,2011-04-01,2011-12-31,2013-02-06 10:43:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3969000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8729000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6412000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-281000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-281000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2350000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7853000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7853000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,357000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8518000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1187000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1079000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2098000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1512000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2266000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2266000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-665000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1165000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1165000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,197000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,171000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-282000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1187000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6290000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6290000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,197000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7997000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7997000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-62000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2YTD,2011-04-01,2011-09-30,2012-11-05 16:26:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-493000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10369000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4035000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8604000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6605000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4335000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4335000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1987000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11504000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5774000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5774000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8596000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1410000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7511000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-472000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7629000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7629000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7629000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,220000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,637000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,295000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-764000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25177000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4441000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4441000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,285000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-60000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3928000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3928000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-495000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1306000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,56000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10716000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2054000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,26399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,26399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2836000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49429000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15045000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2679000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3461000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,FY,2012-04-01,2013-03-31,2015-05-28 17:05:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,131000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3339000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10511000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3855000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23834000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23834000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1880000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31752000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5665000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3TTM,2012-01-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,92000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,637000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2123000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5502000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9049000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9049000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10654000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-90000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,75000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2086000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7832000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2349000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18841000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18841000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2072000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24252000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5824000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5824000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-367000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3YTD,2012-04-01,2012-12-31,2014-02-06 16:05:53+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,75000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,14076000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14076000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9725000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6405000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21056000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21056000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2231000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35251000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7267000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-30215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-30215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,496000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-890000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-841000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2TTM,2011-10-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,607000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2628000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1890000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8403000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8403000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,562000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4472000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1623000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2493000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2525000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2525000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-277000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2YTD,2012-04-01,2012-09-30,2013-11-08 14:17:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1493000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1743000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22977000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22977000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,423000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7856000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8041000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8041000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1734000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-162000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1TTM,2011-07-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,842000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2939000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2582000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7351000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7351000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13277000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,330000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23466000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23466000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2761000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-87776000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8935000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9632000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9632000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,639000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11465000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,FY,2013-04-01,2014-03-31,2016-05-26 16:09:12+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4258000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1370000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-460000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1134000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1519000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1519000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1716000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,218000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7471000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7471000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11903000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-745000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3065000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84257000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73764000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,597000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7741000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4185000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4185000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3TTM,2013-01-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1162000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,541000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1748000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1065000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24481000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26514000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,968000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,968000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12512000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3729000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3729000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9019000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1040000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13571000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13571000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2301000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59080000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52264000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9117000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9117000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7801000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8113000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8113000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,614000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3YTD,2013-04-01,2013-12-31,2015-01-30 15:00:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1106000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2596000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12420000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-389000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20389000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20389000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65278000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5477000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5477000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-14807000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,597000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5078000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-157000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5623000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2TTM,2012-10-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3128000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,298000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-525000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18448000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,426000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3699000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3699000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,512000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1607000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,72000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-664000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-664000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1322000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7271000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2807000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34599000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10085000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10085000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5204000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5204000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,428000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,669000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2YTD,2013-04-01,2013-09-30,2014-11-10 14:36:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,870000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2533000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2577000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22048000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22048000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3077000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54080000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2907000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2907000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11296000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11296000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-107000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7738000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1TTM,2012-07-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,929000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,652000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-711000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16151000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-426000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1505000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1505000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-84000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2276000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,798000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,113688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,113688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-91308000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,43290000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43290000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5188000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,71530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8728000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9523000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9523000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1465000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1485000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,FY,2014-04-01,2015-03-31,2017-05-25 16:08:18+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4266000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-85851000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18263000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18263000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2956000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13640000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16163000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16163000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1117000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1515000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1515000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2441000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4087000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,34922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102357000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73891000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46855000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46855000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,782000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8745000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-748000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3154000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3TTM,2014-01-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1308000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3133000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27991000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6064000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6064000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6064000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-467000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,791000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,14814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1796000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2232000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-73661000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,57890000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,397000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7611000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8008000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8008000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-773000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1438000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3YTD,2014-04-01,2014-12-31,2016-02-05 16:08:32+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1090000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10145000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10145000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14906000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,813000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,28246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3021000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90405000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,782000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5590000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-95000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2TTM,2013-10-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,753000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,575000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4373000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2075000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21146000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,397000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1740000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-307000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17257000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1196000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9902000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9902000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1496000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47890000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,397000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1547000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1944000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1944000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-306000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3433000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2YTD,2014-04-01,2014-09-30,2015-11-04 16:06:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,299000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2477000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13661000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,26689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,26689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2430000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-96149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,86245000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12334000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12334000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,426000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7934000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7934000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,724000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23013000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,698000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,621000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-249000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3190000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3190000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24524000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35730000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13824000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,38147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3277000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7749000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,76795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,76795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15624000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-261725000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,219639000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57710000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57710000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1135000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6025000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-415000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25830000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,FY,2015-04-01,2016-03-31,2018-05-24 16:11:43+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1063000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4945000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7691000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-71380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49444000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,183000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,27149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2214000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22677000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,54238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,54238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7933000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-190345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,170195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28083000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28083000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,451000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-598000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30825000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3YTD,2015-04-01,2015-12-31,2017-02-03 16:06:37+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,724000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,126023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,126023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3188000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,26943000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-83653000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,72501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,72501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10889000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-217192000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,183835000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,849000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5934000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6783000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6783000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1290000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33748000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3TTM,2015-01-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,849000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6534000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4514000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-90593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-485000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,148000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1352000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,28856000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28856000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3419000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99752000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101453000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1718000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1718000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,451000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4544000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-113000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32020000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2YTD,2015-04-01,2015-09-30,2016-11-04 16:16:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,576000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,128152000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128152000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2926000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25383000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-94217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,62244000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62244000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-154590000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125093000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36608000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36608000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,849000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11725000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1492000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11163000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17942000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17942000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57091000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51190000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3339000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-280000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,302000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42661000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50263000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1205000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18030000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,274000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,124256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,124256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2812000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-94647000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6671000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-118645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,86063000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-54950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-54950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10126000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10926000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10926000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1299000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5691000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1317000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,52116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6202000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24072000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32726000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,115116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,115116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50415000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-281400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,205482000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-126333000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-126333000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1720000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3867000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3867000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1841000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9191000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,354000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,FY,2016-04-01,2017-03-31,2019-05-23 16:07:01+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1405000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2099000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18543000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,37255000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,37255000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60812000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-69224000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-69224000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-182000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,951000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9631000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-460000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22029000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,131000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,37217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4488000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14183000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,77861000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,77861000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24039000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-177740000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,144670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57109000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57109000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-264000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,769000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7038000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6533000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6533000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1381000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12838000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,223000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3YTD,2016-04-01,2016-12-31,2018-02-06 16:23:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,26918000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,19734000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,100418000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,100418000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31730000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-249120000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,194114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-86736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-86736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-264000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1453000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5830000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4641000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4641000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7843000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,223000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3TTM,2016-01-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6216000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10947000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,34125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13586000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43505000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27985000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29106000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29106000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1653000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6360000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,134000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2958000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15757000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,43736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10453000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-134235000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,116685000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28003000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28003000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,769000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10213000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6478000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,89000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2YTD,2016-04-01,2016-09-30,2017-11-02 16:33:06+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,43338000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43338000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16218000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,91675000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,91675000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22658000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-296208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,234871000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1453000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8732000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-30000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,89000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2TTM,2015-10-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,832000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1552000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7724000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17356000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17356000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5354000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66917000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69595000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2676000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2676000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,769000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1009000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1695000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1695000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,60000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16435000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,89000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1406000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8033000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4031000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,26380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,26380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5099000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47090000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25327000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25327000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,212000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9957000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,420000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,42198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4020000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30675000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,92261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,92261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18860000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-286382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,216466000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-88776000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-88776000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5272000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-370000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2157000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1TTM,2015-07-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,112170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11005000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,44337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25034000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,192546000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,192546000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-331808000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,206909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-180762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-180762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-517000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2394000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3935000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,302000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,FY,2017-04-01,2018-03-31,2020-05-21 16:08:19+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4641000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2905000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11963000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,56399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,56399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5295000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-121974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-68455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-68455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1331000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1220000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1978000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3796000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,75323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,20350000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,136147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,136147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50568000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-209834000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,148095000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-112307000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-112307000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-517000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1063000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12234000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-690000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11462000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,302000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3YTD,2017-04-01,2017-12-31,2019-02-05 16:29:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,845000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,90222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,34473000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,38893000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,173402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,173402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76944000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-313494000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,208907000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-181531000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-181531000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-699000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2603000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1150000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,433000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3TTM,2017-01-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1515000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2780000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11962000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,56696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,56696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26493000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52679000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1746000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5966000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,43000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,61877000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61877000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20412000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8158000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,79451000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,79451000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24075000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-131934000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,95416000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-60593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-60593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-377000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1063000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-13980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-68000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5496000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,259000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2YTD,2017-04-01,2017-09-30,2018-11-06 16:01:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,584000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,92208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8564000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21332000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,150831000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,150831000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64037000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-279099000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,184213000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-158923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-158923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-740000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1174000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10173000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,524000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2TTM,2016-10-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1429000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2857000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4509000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,43157000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43157000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14271000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57908000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28794000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1063000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-346000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,566000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2463000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12667000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9804000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74026000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,66622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-184000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-14250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-14434000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-14434000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,278000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4930000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,76580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7259000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25163000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16028000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,125030000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,125030000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55120000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-288108000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,225014000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-118214000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-118214000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-630000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1720000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-435000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,655000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,655000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1775000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,484000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1TTM,2016-07-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1464000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,259016000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,259016000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14121000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29305000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-47501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,252197000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,252197000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44004000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-404337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,331886000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-116455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-116455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-58827000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-55775000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-55775000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,78046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,FY,2018-04-01,2019-03-31,2020-05-21 16:08:19+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5290000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,73960000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73960000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4185000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-18182000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11528000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,70391000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,70391000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-132156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104937000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35754000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35754000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1676000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1343000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3019000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3019000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-816000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36840000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,790000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,185056000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,185056000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9936000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1644000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47487000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59029000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,181806000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,181806000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-272181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,226949000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80701000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80701000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-60170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-58794000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-58794000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41206000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3YTD,2018-04-01,2018-12-31,2020-02-06 16:07:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,221903000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,221903000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12841000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1644000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,59450000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-54345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,238205000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,238205000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40764000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-394155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,285763000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-149156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-149156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2707000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-58950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33679000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3TTM,2018-01-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8296000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,44863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3589000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-796000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17108000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9851000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,74615000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,74615000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-147799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65818000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65818000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1117000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,118000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,970000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,140193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,140193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6347000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30379000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-68880000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,107191000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,107191000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,136844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1375000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-59053000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-57678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-57678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1223000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33407000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2YTD,2018-04-01,2018-09-30,2019-10-31 16:13:44+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,190486000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,190486000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12032000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,54304000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-35688000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,220286000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,220286000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59133000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-324256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,248337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-135052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-135052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2706000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-56087000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-53521000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-53521000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,133000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31846000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,43000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2TTM,2017-10-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7587000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3388000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-485000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17049000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9519000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,60560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,60560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98514000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49650000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49650000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1375000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2747000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,62000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15094000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2959000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13330000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59361000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,46631000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,46631000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75782000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-61800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-61800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-61800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1285000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2956000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,164862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,164862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,48543000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,202883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,202883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61206000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-283650000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,216069000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-128787000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-128787000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-333000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2394000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-58564000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-275000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1TTM,2017-07-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7118000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,31798000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31798000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6003000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-53000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25864000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,22981000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,86593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,86593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10546000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-119825000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,140332000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-25003000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-21765000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-21765000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-418000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,74371000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q4,2020-01-01,2020-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2206000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,203009000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,203009000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20430000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2731000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49701000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,44511000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,314920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,314920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44006000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-632237000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,550788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-125455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-125455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-84879000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5103000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37939000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-117715000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-117715000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-430000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,71320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,FY,2019-04-01,2020-03-31,2020-05-21 16:08:19+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9685000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,245171000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,245171000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-3778000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5655000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33058000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,298718000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,298718000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-644568000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,515393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-171170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-171170000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-59876000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4044000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37099000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-92931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-92931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-828000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33789000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3TTM,2019-01-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8269000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,69217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5375000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10860000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26110000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,89440000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,89440000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8853000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-236127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,147575000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-97405000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-97405000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-25003000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,64000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24939000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24945000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32309000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,171211000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,171211000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14427000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23837000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,228327000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,228327000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33460000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-512412000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,410456000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-135416000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-135416000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-59876000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-38442000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-95950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-95950000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3051000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q3YTD,2019-04-01,2019-12-31,2020-02-06 16:07:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,220817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,220817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-4172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,33623000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,283893000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,283893000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41266000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-556240000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,457923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-139583000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-139583000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-34873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4045000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-38280000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-69108000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-69102000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1311000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73897000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2TTM,2018-10-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8109000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13071000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13071000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4687000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-970000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,59992000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2521000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,74259000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,74259000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12357000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-149418000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,169701000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7926000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7926000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-34873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,730000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-31775000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-31729000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1225000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49231000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3765000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,101994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,101994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2276000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,34697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,138887000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,138887000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24607000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-276285000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,262881000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38011000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38011000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-34873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-38506000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-71011000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-71005000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-613000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29258000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q2YTD,2019-04-01,2019-09-30,2019-10-31 16:13:44+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6349000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,257873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,257873000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-3687000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9801000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,270194000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,270194000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41107000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-505336000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,349284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-197159000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-197159000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-36263000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-33211000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-33251000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-24000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39760000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1TTM,2018-07-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4918000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,88923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1306000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-25295000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,64628000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,64628000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-126867000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,93180000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45937000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45937000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-39236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-39236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-39276000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2020.0,Q1,2019-04-01,2019-06-30,2019-08-01 16:07:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2584000.0
